Your browser doesn't support javascript.
loading
Severe periocular bleeding induced by bevacizumab in a patient with recurrent glioblastoma multiforme.
Eryilmaz, Melek K; Mutlu, Hasan; Yalçin Müsri, Fatma; Salim, Derya K; Tazegül, Gökhan; Coskun, Hasan S.
Afiliação
  • Eryilmaz MK; 1 Department of Medical Oncology, Akdeniz University School of Medicine, Antalya, Turkey.
  • Mutlu H; 1 Department of Medical Oncology, Akdeniz University School of Medicine, Antalya, Turkey.
  • Yalçin Müsri F; 1 Department of Medical Oncology, Akdeniz University School of Medicine, Antalya, Turkey.
  • Salim DK; 1 Department of Medical Oncology, Akdeniz University School of Medicine, Antalya, Turkey.
  • Tazegül G; 2 Department of Internal Medicine, Akdeniz University School of Medicine, Antalya, Turkey.
  • Coskun HS; 1 Department of Medical Oncology, Akdeniz University School of Medicine, Antalya, Turkey.
J Oncol Pharm Pract ; 23(5): 392-395, 2017 Jul.
Article em En | MEDLINE | ID: mdl-27105898

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Bevacizumab / Antineoplásicos Imunológicos / Hemorragia / Recidiva Local de Neoplasia Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Bevacizumab / Antineoplásicos Imunológicos / Hemorragia / Recidiva Local de Neoplasia Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article